U.S. House · 118th Congress · H.R. 6400
H.R. 6400
To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Tony CárdenasD-CA-29
- Introduced
- November 14, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.